Navigation Links
Watson Full Year 2011 Net Revenue Increases 29% to $4.58 Billion;
Date:2/14/2012

the amortization of atorvastatin product rights acquired in the Arrow acquisition and product rights acquired in the Specifar acquisition.

For the full year 2011, consolidated general and administrative expenses were $353.1 million, compared to $436.1 million in the prior year, a decrease of $83.0 million. The prior year includes a $129.9 million reserve associated with drug pricing litigation.  Amortization expense for the full year 2011 was $354.3 million, compared to $180.0 million in full year 2010.

2012 Financial Outlook Watson's estimates are based on actual results for 2011 and management's current belief about prescription trends, pricing levels, inventory levels and the anticipated timing of future product launches and events.  

-- Watson estimates total net revenue for 2012 will be approximately $5.4 billion.

  • Total Global Generics segment revenue of between $3.9 and $4.1 billion.
  • Total Global Brands segment revenue of between $500 and $525 million.
  • Total Anda Distribution segment revenue of between $850 and $900 million.
  • Adjusted non-GAAP earnings for 2012 is expected to be between $5.50 and $5.80 per diluted share.
  • Adjusted EBITDA for 2012 is expected to be between $1.3 and $1.375 billion.

  • Webcast and Conference Call DetailsWatson will host a conference call and webcast today at 8:30 a.m. Eastern Standard Time to discuss fourth quarter and full year 2011 results, the outlook for 2012 and recent corporate developments.  The dial-in number to access the call is (877) 251-7980, or from international locations, (706) 643-1573.  The Conference ID is 44986086.

    A taped replay of the conference call will also be available beginning approximately two hours after the call's conclusion and will remain available through 12:00 midnight Eastern Time on February 28, 2012.  The replay may be accessed by dialing (855) 859-2056 and entering the same Confer
    '/>"/>

    SOURCE Watson Pharmaceuticals, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

    Related medicine technology :

    1. Watson Launches Generic Biaxin(R) XL
    2. Watson Announces Positive Results From Its Pivotal Study of Oxybutynin Topical Gel for the Treatment of Overactive Bladder
    3. Watson Announces Silodosin NDA Accepted for Filing by FDA for the Treatment of Benign Prostatic Hyperplasia
    4. Watson Announces Positive Data for Its New Investigational Products for Benign Prostatic Hyperplasia and Overactive Bladder
    5. Watson Announces United States Availability of RAPAFLO(TM) (silodosin), a Novel New Treatment in Benign Prostatic Hyperplasia (BPH)
    6. Watson and Barr Settle Lawsuit Over Oxytrol(R)
    7. Watson to Host Conference Call and Webcast to Discuss Fourth Quarter 2009 Earnings and 2010 Outlook
    8. Watson Completes Acquisition of Eden Biodesign
    9. Watson to Present at Credit Suisse Healthcare Conference
    10. Watson Announces New Program to Help Promote Good Bone Health in Advanced Prostate Cancer Patients on Long-Term Androgen Deprivation Therapy
    11. Watson Files FDA Application for Generic Rozerem(R)
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/27/2015)... 27, 2015 ieCrowd™ today announced the ... development of the company,s supplemental oxygen delivery device, ... being developed by ieCrowd,s subsidiary Smart Oxygen Solutions ... demand for oxygen based on level of activity.  ... for the Smart Oxygen device would require a ...
    (Date:8/27/2015)... , Aug. 27, 2015  Now that Intuitive ... Da Vinci S™ surgical robot, hospitals with robotic surgery ... They also need to see where they stand with ... the right patients? Have they adopted best practices for ... program in the future? ECRI Institute, which ...
    (Date:8/27/2015)...  MiMedx Group, Inc. (NASDAQ: MDXG ), ... tissue and patent-protected processes to develop and market ... Surgical, Orthopedic, Spine, Sports Medicine, Ophthalmic and Dental ... multiple inaccuracies in the press release issued by ... rulings from the Patent Trial and Appeal Board ...
    Breaking Medicine Technology:Smart Oxygen Solutions' Supplemental Oxygen Delivery Device Achieves FDA Regulatory Pathway Milestone 2Smart Oxygen Solutions' Supplemental Oxygen Delivery Device Achieves FDA Regulatory Pathway Milestone 3Smart Oxygen Solutions' Supplemental Oxygen Delivery Device Achieves FDA Regulatory Pathway Milestone 4ECRI Institute's New Robotic Surgery Service Helps Hospitals Brace for Change 2ECRI Institute's New Robotic Surgery Service Helps Hospitals Brace for Change 3MiMedx Corrects Inaccuracies In MTF Press Release Regarding The Recent Rulings From The Patent Trial And Appeal Board 2MiMedx Corrects Inaccuracies In MTF Press Release Regarding The Recent Rulings From The Patent Trial And Appeal Board 3MiMedx Corrects Inaccuracies In MTF Press Release Regarding The Recent Rulings From The Patent Trial And Appeal Board 4
    ... announced today the company has reached another major milestone ... management team roster. DiFUSION Technologies is ... commercialization of its proprietary CleanFUZE ™ anti-microbial technology ... line of Posterior Interbody products. "In ...
    ... supplier of comprehensive patient management solutions, today introduced its ... TrendSetter collects patient compliance data from any brand of ... to home health providers. This allows the providers to ... Other solutions only work for single brands of PAP ...
    Cached Medicine Technology:DiFUSION Technologies Adds Accomplished Senior Management Team 2DiFUSION Technologies Adds Accomplished Senior Management Team 3DiFUSION Technologies Adds Accomplished Senior Management Team 4DiFUSION Technologies Adds Accomplished Senior Management Team 5
    (Date:8/28/2015)... ... August 28, 2015 , ... With the goal of furthering music ... second year to the Adams County Fairgrounds in Mendon, IL on May 30th, 2015. ... to support music education in the underfunded school districts of Mendon and its neighboring ...
    (Date:8/28/2015)... ... August 28, 2015 , ... The 6th Annual Survivor in the City, ... added yet another accolade to its cadre of widespread support—an official letter of support ... help of the medical community and the University of Illinois at Chicago’s Department of ...
    (Date:8/28/2015)... ... August 28, 2015 , ... “ Frequentz ” was ... the latest and coolest applications on the market for iOS, Android, and Windows. Joe ... with viewers how this software allows businesses to track product movement from beginning to ...
    (Date:8/28/2015)... ... August 28, 2015 , ... ... Award, honoring military veterans leading in business. Mr. Troy Mizell, Chairman of ... The inaugural Nashville Business Journal's 2015 Veterans Awards will recognize Nashville military veterans ...
    (Date:8/28/2015)... ... ... The Quatela Center for Plastic Surgery is excited to bring patients the ... by the Food and Drug Administration to eliminate submental fat, also known as the ... are among the premier cosmetic surgeons in Rochester to offer this innovative procedure.     , ...
    Breaking Medicine News(10 mins):Health News:Best Drug Rehabilitation Interviews Country-Rock Duo Highway Run at the 2015 "Music With A Mission" Benefit Concert 2Health News:Chicago Mayor Pens Official Support of Annual Survivor in the City Event Benefitting Brain Aneurysm Foundation 2Health News:Chicago Mayor Pens Official Support of Annual Survivor in the City Event Benefitting Brain Aneurysm Foundation 3Health News:Track Product Movement from Beginning to End with Frequentz 2Health News:MyGenetx Board Member Receives Veterans Award 2Health News:Non-surgical Treatment to Get Rid of The "Double Chin," Kybella™, Now Available at the Quatela Center for Plastic Surgery 2Health News:Non-surgical Treatment to Get Rid of The "Double Chin," Kybella™, Now Available at the Quatela Center for Plastic Surgery 3
    ... XTENT, Inc.,(Nasdaq: XTNT ) today reported financial results for ... company reported a net loss and net loss attributable to ... fourth quarter,of 2007, compared to a net loss and net ... share, for the same period in,2006. The company,s net loss ...
    ... , , TUESDAY, Feb. 19 (HealthDay News) -- Studies show no ... the sudden collapse of kidney function that carries with it ... analysis of 38 trials found no difference in the death ... method or another, according to a report in the ...
    ... reaction to sounds, might be way to spot hearing problems, study ... not just be a window to the soul, they may also ... , A new study reports that the eyes can provide clues ... may be especially helpful for diagnosing hearing problems in babies, very ...
    ... isotopes for peacetime uses at Oak Ridge National Laboratory ... by the American Chemical Society in a special ceremony ... Bruce E. Bursten, Ph.D., president of the Society, will ... director of ORNL. Bursten said the distribution of radioisotopes, ...
    ... Current Hospital, WALLA WALLA, Wash., Feb. 19 ... announced today the Department of,Veterans Affairs (VA) will ... health at the Walla Walla VA,Medical Center., ... the health care,needs of Washington,s veterans and recognizes ...
    ... Middle-aged women who suffered physical or sexual abuse as ... costs, according to a long-term study of more than 3,000 ... used health services at significantly higher rates than did non-abused ... with an average age in their late 40s still suffer ...
    Cached Medicine News:Health News:XTENT Announces 2007 Financial Results 2Health News:XTENT Announces 2007 Financial Results 3Health News:XTENT Announces 2007 Financial Results 4Health News:XTENT Announces 2007 Financial Results 5Health News:XTENT Announces 2007 Financial Results 6Health News:No Difference Found in Treatments for Acute Kidney Failure 2Health News:No Difference Found in Treatments for Acute Kidney Failure 3Health News:Eyes a Window to Hearing Loss? 2Health News:Eyes a Window to Hearing Loss? 3Health News:Peacetime use of radioisotopes at Oak Ridge cited as Chemical Landmark 2Health News:Peacetime use of radioisotopes at Oak Ridge cited as Chemical Landmark 3Health News:Women who suffered child abuse spend more on health care 2Health News:Women who suffered child abuse spend more on health care 3
    ... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
    ... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
    ... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
    ... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
    Medicine Products: